Medicortex Finland Oy

Medicortex is developing a diagnostic kit to rapidly detect biomarkers of traumatic brain injury from urine and saliva.

Finland, Turku

www.medicortex.fi

Problem & Solution

Traumatic Brain Injury (TBI), or concussion in its mildest form, are a consequence of an impact to head or a sudden movement of head. Every year, 2.5 M people in Europe, 2.8 M in the USA, and more than 50 M worldwide suffer a TBI. It is typically diagnosed by a neurological examination, based on various responses the suspected patient expresses. Head scans by means CT or MRI have quite poor sensitivity for mild TBI and concussion. Currently, there are no biochemical laboratory tests in routine clinical use, to support the diagnosis of TBI by the physician. The uncertainties in the diagnostics of TBI leave several sufferers of TBI unaware of their condition, which may lead to worse chronic and, even fatal, conditions eventually.
Medicortex' solution for the huge unmet diagnostic need is a rapid test that detects biomarkers of TBI from a sample of urine and saliva. Because of its non-invasive nature, the kit can be used for rapid point-of-care confirming or ruling out TBI.

Donatas B. would like to know:

Do you already have committed customers?

Medicortex has signed an agreement with Pro-Lab diagnostics — please see PR:
https://www.businesswire.com/news/home/20180522005889/en/Medicortex-Finland-Announces-Agreement-Pro-Lab

All other information about customers and distributors is confidential at this stage — Thank you for your interest in Medicortex.